newsfilter
← Latest News
GlobeNewswire·

Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement

NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Cellectis (NASDAQ:CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus